BioLife Solutions, Inc. (BLFS) has a negative trailing P/E of -79.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 137.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.27%, forward earnings yield 0.73%. PEG 1.57.
Criteria proven by this page:
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -3.0 | -0.05 | 6.43 | 2.47 | - |
| 2017 | -31.6 | 0.52 | 7.89 | 7.22 | 0.13% |
| 2018 | 59.9 | 0.09 | 4.53 | 9.91 | 0.22% |
| 2019 | -190.0 | 2.01 | 3.79 | 11.50 | - |
| 2020 | 408.4 | -2.29 | 5.31 | 22.65 | - |
| 2021 | -161.1 | 0.36 | 2.99 | 12.04 | - |
| 2022 | -5.5 | 0.00 | 2.12 | 10.14 | - |
| 2023 | -10.7 | 0.20 | 2.10 | 9.37 | - |
| 2024 | -59.2 | 0.83 | 3.43 | 14.54 | - |
| 2025 | -95.2 | 2.20 | 3.10 | 12.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.54 | $8.23M | $-6.88M | -83.6% |
| 2017 | $-0.19 | $11.02M | $-2.52M | -22.8% |
| 2018 | $0.20 | $19.74M | $3.27M | 16.5% |
| 2019 | $-0.09 | $27.37M | $11.06M | 40.4% |
| 2020 | $0.10 | $48.09M | $2.67M | 5.5% |
| 2021 | $-0.22 | $119.16M | $-8.38M | -7% |
| 2022 | $-3.29 | $161.76M | $-139.81M | -86.4% |
| 2023 | $-1.52 | $143.27M | $-66.43M | -46.4% |
| 2024 | $-0.44 | $82.25M | $-20.18M | -24.5% |
| 2025 | $-0.25 | $96.21M | $-12.13M | -12.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.15 | $0.08 – $0.21 | $112.94M | $112.11M – $113.61M | 3 |
| 2027 | $0.34 | $0.33 – $0.35 | $133.06M | $130.55M – $135.57M | 2 |
| 2028 | $0.88 | $0.86 – $0.90 | $165.41M | $163.56M – $167.26M | 1 |
| 2029 | $1.31 | $1.28 – $1.34 | $199.41M | $196.08M – $202.84M | 1 |
| 2030 | $1.81 | $1.77 – $1.85 | $239.27M | $235.27M – $243.39M | 1 |
